scholarly journals An assessment of the centrally acting muscle relaxant tolperisone on driving ability and cognitive effects compared to placebo and cyclobenzaprine

2020 ◽  
Vol 45 (4) ◽  
pp. 774-782 ◽  
Author(s):  
Judy Caron ◽  
Randall Kaye ◽  
Thomas Wessel ◽  
Amy Halseth ◽  
Gary Kay
Keyword(s):  
Muscle Relaxant ◽  
Driving Ability ◽  
Cognitive Effects ◽  
Acting Muscle

scholarly journals Silperisone: A Centrally Acting Muscle Relaxant

2006 ◽  
Vol 12 (3-4) ◽  
pp. 218-235 ◽  
Author(s):  
Sándor Farkas
Keyword(s):  
Muscle Relaxant ◽  
Acting Muscle

Mivacurium When Preceded by Pancuronium Becomes a Long-Acting Muscle Relaxant

1997 ◽  
Vol XLI (3) ◽  
pp. 173
Author(s):  
OLLI ERKOLA ◽  
PEKKA RAUTOMA ◽  
OLLI A. MERETOJA
Keyword(s):  
Muscle Relaxant ◽  
Long Acting ◽  
Acting Muscle

scholarly journals Reduction of Tinnitus Severity by the Centrally Acting Muscle Relaxant Cyclobenzaprine: An Open-Label Pilot Study

2012 ◽  
Vol 17 (3) ◽  
pp. 179-188 ◽  
Author(s):  
Claudia Coelho ◽  
Ricardo Figueiredo ◽  
Elmar Frank ◽  
Julia Burger ◽  
Martin Schecklmann ◽  
...  
Keyword(s):  
Pilot Study ◽  
Muscle Relaxant ◽  
Open Label ◽  
Tinnitus Severity ◽  
Acting Muscle

Cyclobenzaprine, a centrally acting muscle relaxant, acts on descending serotonergic systems

1996 ◽  
Vol 311 (1) ◽  
pp. 29-35 ◽  
Author(s):  
Hiroyuki Kobayashi ◽  
Yutaka Hasegawa ◽  
Hideki Ono
Keyword(s):  
Muscle Relaxant ◽  
Acting Muscle

Clinical Signs with Modified Electroconvulsive Therapy

1963 ◽  
Vol 109 (460) ◽  
pp. 399-403 ◽  
Author(s):  
J. G. Whitwam ◽  
T. Moreton ◽  
J. Norman
Keyword(s):  
Electroconvulsive Therapy ◽  
Muscle Relaxant ◽  
Parasympathetic Nervous System ◽  
Clinical Signs ◽  
Short Acting ◽  
Neurological Signs ◽  
Clinical Description ◽  
Modified Electroconvulsive Therapy ◽  
Acting Muscle ◽  
Stimulation Of

In many electroconvulsive therapy centres atropine is used to mitigate adverse effects resulting from stimulation of the parasympathetic nervous system, while the violence of muscular contractions is controlled with a muscle relaxant. It is customary to secure hypnosis with a short acting barbiturate prior to administration of the relaxant. The first report of the use of thiopentone for E.C.T. was by Rubinstein (1945), and methohexitone (Lilly 25398) was introduced by Friedman (1959). The use of succinylcholine (iodide) for E.C.T. was first reported by Holmberg and Thesleff (1951). The neurological signs during unmodified E.C.T. have been well documented (e.g. Klein and Early, 1948a, 1948b, 1949; Kalinowsky and Hoch, 1952). There is as yet no comparable detailed clinical description of E.C.T. when modified by atropine and a short acting muscle relaxant preceded by a barbiturate. This discussion is limited to some of those signs which may be of assistance in the management of therapy.

scholarly journals Tolperisone, a centrally-acting muscle relaxant: a possible cause of macular haemorrhage

Eye ◽  
2019 ◽  
Vol 34 (8) ◽  
pp. 1380-1381 ◽  
Author(s):  
Georgios Tsokolas ◽  
Hussein Almuhtaseb ◽  
Abdul Hanifudin ◽  
Andrew Lotery
Keyword(s):  
Muscle Relaxant ◽  
Possible Cause ◽  
Acting Muscle
Sign in / Sign up

Export Citation Format

Share Document